30day Notice

85546

Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices
TOTAL ESTIMATED ANNUALIZED BURDEN HOURS
Number of
respondents

Form name

Total
responses

Average
burden per
response
(in hours)

Total
burden
hours

BHI EB-TNP Outcome Measurement Report ......................

27

1

27

5

135

Total ..............................................................................

27

........................

27

........................

135

HRSA specifically requests comments
on (1) the necessity and utility of the
proposed information collection for the
proper performance of the agency’s
functions; (2) the accuracy of the
estimated burden; (3) ways to enhance
the quality, utility, and clarity of the
information to be collected; and (4) the
use of automated collection techniques
or other forms of information
technology to minimize the information
collection burden.
Maria G. Button,
Director, Executive Secretariat.
[FR Doc. 2024–24962 Filed 10–25–24; 8:45 am]
BILLING CODE 4165–15–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Submission for OMB Review; 30-Day
Comment Request; Electronic
Individual Development Plan (eIDP)
(National Eye Institute)
AGENCY:

National Institutes of Health,

HHS.
ACTION:

Notice.

In compliance with the
Paperwork Reduction Act of 1995, the
National Institutes of Health (NIH) has
submitted to the Office of Management
and Budget (OMB) a request for review
and approval of the information
collection listed below.
DATES: Comments regarding this
information collection are best assured
of having their full effect if received
within 30-days of the date of this
publication.
ADDRESSES: Written comments and
recommendations for the proposed
information collection should be sent
within 30 days of publication of this
notice to www.reginfo.gov/public/do/
PRAMain. Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function.
FOR FURTHER INFORMATION CONTACT: To
obtain a copy of the data collection
plans and instruments, submit
SUMMARY:

lotter on DSK11XQN23PROD with NOTICES1

Number of
responses per
respondent

VerDate Sep<11>2014

19:13 Oct 25, 2024

Jkt 265001

comments in writing, or request more
information on the proposed project,
contact: Dr. Cesar E. Perez-Gonzalez,
Training Director, Office of the
Scientific Director, National Eye
Institute, NIH, Building 31, Room 6A22,
MSC 0250, Bethesda, Maryland 20892
or call non-toll-free number (301) 451–
6763 or Email your request, including
your address to: cesarp@nei.nih.gov.
Formal requests for additional plans and
instruments must be requested in
writing.
SUPPLEMENTARY INFORMATION: This
proposed information collection was
previously published in the Federal
Register on August 1, 2024, 89 FR 62749
and allowed 60 days for public
comment. No public comments were
received. The purpose of this notice is
to allow an additional 30 days for public
comment.
The National Eye Institute (NEI),
National Institutes of Health, may not
conduct or sponsor, and the respondent
is not required to respond to, an
information collection that has been
extended, revised, or implemented on or
after October 1, 1995, unless it displays
a currently valid OMB control number.
In compliance with Section
3507(a)(1)(D) of the Paperwork
Reduction Act of 1995, the National
Institutes of Health (NIH) has submitted
to the Office of Management and Budget
(OMB) a request for review and
approval of the information collection
listed below.
Proposed Collection: Electronic
Individual Development Plans, 0925–
0772 and 10/31/2024-Extension,
National Eye Institute (NEI), National
Institutes of Health (NIH).
Need and Use of Information
Collection: The National Eye Institute’s
(NEI) Office of the Scientific Director
(OSD) goal is to train the next
generation of vision researchers and
ophthalmologists. Trainees who
participate in NEI research come with
different levels of education (student,
postbaccalaureate, predoctoral
including graduate and medical
students, postdoctoral fellows) and for
different amounts of time (6 months to
5 years). Training at the NEI focuses on
scientific and professional skill

PO 00000

Frm 00059

Fmt 4703

Sfmt 4703

development. To enhance their chances
of obtaining their ideal career,
completing an annual Individual
Development Plan (IDP) is an important
step in helping a trainee’s career and
professional development and is
standard practice in graduate and
postdoctoral education. An IDP is an
effective tool for trainees to think about
their career goals and skills needed to
achieve them during their time at the
NEI. Trainees work together with their
research mentor to organize and
summarize their research projects,
consider career goals, and set training
goals and expectations, both for the
mentee and mentor.
This information collection request is
to implement an electronic Individual
Development Plan (eIDP). The data
collected comes from a detailed
questionnaire focused on responses to
professional goals and expectations
while they are at the NEI. It is expected
that the trainees will complete the eIDP
annually and by doing so, it will help
enhance the effectiveness of their
training by setting clear goals that can
be monitored not only by the trainee
themselves but also by their mentor, the
Training Director, and their
Administrative Officer. In addition to
this eIDP, the system will also
implement an electronic exit survey.
The data collected comes from a
detailed questionnaire focused on
responses to questions focused on
trainee mentoring and professional
experiences at the NEI as well as their
plans after they depart. It is expected
that the trainees will complete at the
end of their tenure and that by doing so,
the NEI Training Program can learn
about ways to improve career
development opportunities for future
trainees as well as learn more about
trainee job choices to better advise
fellows. Additionally, we can use the
survey to help determine mentor
effectiveness and help identify problems
in mentoring at the NEI.
OMB approval is requested for 3
years. There are no costs to respondents
other than their time. The total
estimated annualized burden hours are
213.

E:\FR\FM\28OCN1.SGM

28OCN1

85547

Federal Register / Vol. 89, No. 208 / Monday, October 28, 2024 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS

Total
annual
burden
hour

eIDP (Attachment 1) ................................................................
Exit Survey Part 1 (Attachment 2) ..........................................
Exit Survey Part 2 (Attachment 3) ..........................................

Individuals ..............
Individuals ..............
Individuals ..............

150
150
150

1
1
1

1
5/60
20/60

150
13
50

Total ..................................................................................

................................

......................

450

......................

213

and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)

Dated: October 23, 2024.
Cesar E. Perez-Gonzalez,
Training Director, National Eye Institute,
National Institutes of Health.

Dated: October 22, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.

[FR Doc. 2024–25017 Filed 10–25–24; 8:45 am]
BILLING CODE 4140–01–P

[FR Doc. 2024–24975 Filed 10–25–24; 8:45 am]

DEPARTMENT OF HEALTH AND
HUMAN SERVICES

BILLING CODE 4140–01–P

National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.

lotter on DSK11XQN23PROD with NOTICES1

Average
time per
response
(in hours)

Type of
respondent

Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01 Clinical
Trial Not Allowed).
Date: November 21, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G34,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Vishakha Sharma, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G34, Rockville, MD
20892, 301–761–7036, vishakha.sharma@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,

VerDate Sep<11>2014

19:13 Oct 25, 2024

Jkt 265001

Number of
respondents

Number of
responses per
respondent

Form name

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel: Tailoring HIV Curative
Strategies to the Participant (UM1 Clinical
Trial Not Allowed).
Date: December 2–3, 2024.
Time: 9:30 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Kristina S. Wickham,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G22,

PO 00000

Frm 00060

Fmt 4703

Sfmt 4703

Rockville, MD 20892, 301–761–5390,
kristina.wickham@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: October 22, 2024.
Lauren A. Fleck,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2024–24980 Filed 10–25–24; 8:45 am]
BILLING CODE 4140–01–P

DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 1009 of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Clinical Trial
Implementation Cooperative Agreement (U01
Clinical Trial Required).
Date: November 19, 2024.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G11,
Rockville, MD 20892 (Video Assisted
Meeting).
Contact Person: Barry J. Margulies, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,

E:\FR\FM\28OCN1.SGM

28OCN1